Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 218863
Company: AMNEAL
Company: AMNEAL
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 2MG | TABLET, FOR SUSPENSION;ORAL | Prescription | AB | No | No |
| EVEROLIMUS | EVEROLIMUS | 3MG | TABLET, FOR SUSPENSION;ORAL | Prescription | AB | No | No |
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET, FOR SUSPENSION;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/10/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
EVEROLIMUS
TABLET, FOR SUSPENSION;ORAL; 2MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AFINITOR DISPERZ | EVEROLIMUS | 2MG | TABLET, FOR SUSPENSION;ORAL | Prescription | Yes | AB | 203985 | NOVARTIS PHARM |
| EVEROLIMUS | EVEROLIMUS | 2MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 218863 | AMNEAL |
| EVEROLIMUS | EVEROLIMUS | 2MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 217216 | BIOCON PHARMA |
| EVEROLIMUS | EVEROLIMUS | 2MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 217640 | NATCO |
TABLET, FOR SUSPENSION;ORAL; 3MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AFINITOR DISPERZ | EVEROLIMUS | 3MG | TABLET, FOR SUSPENSION;ORAL | Prescription | Yes | AB | 203985 | NOVARTIS PHARM |
| EVEROLIMUS | EVEROLIMUS | 3MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 218863 | AMNEAL |
| EVEROLIMUS | EVEROLIMUS | 3MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 217216 | BIOCON PHARMA |
| EVEROLIMUS | EVEROLIMUS | 3MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 217640 | NATCO |
TABLET, FOR SUSPENSION;ORAL; 5MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AFINITOR DISPERZ | EVEROLIMUS | 5MG | TABLET, FOR SUSPENSION;ORAL | Prescription | Yes | AB | 203985 | NOVARTIS PHARM |
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 218863 | AMNEAL |
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 217216 | BIOCON PHARMA |
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET, FOR SUSPENSION;ORAL | Prescription | No | AB | 217640 | NATCO |